Equities

medmix AG

medmix AG

Actions
  • Price (USD)17.40
  • Today's Change0.00 / 0.00%
  • Shares traded2.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 04 2024 14:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CHF
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments112317210
Total Receivables, Net746737
Total Inventory889279
Prepaid expenses101211
Other current assets, total232.302.00
Total current assets308489340
Property, plant & equipment, net258230230
Goodwill, net269254258
Intangibles, net128120136
Long term investments136.50--
Note receivable - long term0.300.100
Other long term assets--00.20
Total assets1,0071,106974
LIABILITIES
Accounts payable494741
Accrued expenses313628
Notes payable/short-term debt000
Current portion long-term debt/capital leases4216424
Other current liabilities, total562324
Total current liabilities178271117
Total long term debt308309297
Total debt350474321
Deferred income tax191620
Minority interest9.00----
Other liabilities, total284.506.80
Total liabilities542601441
SHAREHOLDERS EQUITY
Common stock0.400.400.40
Additional paid-in capital------
Retained earnings (accumulated deficit)530540553
Treasury stock - common(15)(13)(6.5)
Unrealized gain (loss)------
Other equity, total(50)(23)(13)
Total equity465505534
Total liabilities & shareholders' equity1,0071,106974
Total common shares outstanding414141
Treasury shares - common primary issue0.480.350.15
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.